DNA Quantification and Fragmentation in Sputum after Inhalation of Recombinant Human Deoxyribonuclease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000149813PMID 18769062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Young, Mechanically Ventilated Children

  2006cited by this paper
• DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: Influence of treatment with dornase alpha

  2005cited by this paper
• Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.

  2004cited by this paper
• Effect of DNase on exercise capacity in cystic fibrosis

  2004cited by this paper
• Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.

  2002cited by this paper
• Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.

  2002cited by this paper
• Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus

  2000cited by this paper
• Multicenter, open‐label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease

  1998cited by this paper
• rhDNase in acute asthma.

  1997cited by this paper
• rhDNase in acute asthma.

  1997cited by this paper
• Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.

  1997cited by this paper
• The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.

  1996cited by this paper
• Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.

  1996cited by this paper
• Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with Nacystelyn and rhDNase

  1996cited by this paper
• Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase

  1996cited by this paper
• In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.

  1996cited by this paper
• Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.

  1996cited by this paper
• DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.

  1995cited by this paper
• Recombinant human DNase in management of lobar atelectasis due to retained secretions.

  1995cited by this paper
• Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome

  1995cited by this paper
• Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification.

  1995cited by this paper
• Aerosolized Dornase alpha (rhDNase) in cystic fibrosis

  1995cited by this paper
• Aerosolized dornase alpha (rhDNase) in cystic fibrosis.

  1995cited by this paper
• Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

  1994cited by this paper
• Clinical trials of recombinant human DNase in cystic fibrosis patients.

  1993cited by this paper
• Clinical trials of recombinant human DNase in cystic fibrosis patients

  1993cited by this paper
• Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.

  1992cited by this paper
• Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

  1990cited by this paper
• THE ESTIMATION OF DEOXYRIBONUCLEIC ACID IN THE PRESENCE OF SIALIC ACID: APPLICATION TO ANALYSIS OF HUMAN GASTRIC WASHINGS.

  1965cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper

• Mucoactive agents for adults with acute lung conditions: A systematic review

  2019cites this paper
• Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis

  2017cites this paper
• Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center

  2016cites this paper
• Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis

  2015cites this paper
• Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study

  2013cites this paper
• Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients.

  2013cites this paper
• Die Therapie von Atelektasen mit rekombinanter humaner Desoxyribonuklease bei intubierten pädiatrischen Patienten

  2009cites this paper
• Therapeutic Efficacy and Safety of Amitriptyline in Patients with Cystic Fibrosis

  2009cites this paper
• Clinical and in vitro Effect of Dornase Alfa in Mechanically Ventilated Pediatric Non-Cystic Fibrosis Patients with Atelectases

  2009cites this paper